DealZone

M & A wrap: AstraZeneca in the mood for a deal?

September 8, 2011

AstraZeneca may decide to make a big acquisition if it fails to improve the flow of new drugs from its pipeline and its $10 billion cash pile hints at a desire to keep strategic options open, according to an analyst report.

The Washington Post has lost money for three years and some shareholders of owner The Washington Post Co wouldn’t weep if the paper were sold, allowing the company to focus on its for-profit education and cable businesses, write  Sruthi Ramakrishnan and A. Ananthalakshmi.

Singapore Exchange’s  coup in luring Manchester United to the city is threatening to turn sour as the bourse comes under fire for plans to let the club list using a structure that will minimize the influence of new shareholders.

SABMiller is set to launch its formal takeover for Foster’s Group this month after an Australian regulator rejected its claim that Foster’s had made misleading financial statements as part of a hostile $10.1 billion bid battle.

Victor Muller, the man who came to Saab’s rescue the last time it was on the brink of collapse, is famous for his unbounded optimism, but even fans of the marque wonder if the 51-year-old car enthusiast may have to admit defeat.

Post Your Comment

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/